Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Intravenous Solutions Market Through 2034?
The market size for intravenous solutions has seen substantial growth in the past few years. The market value is forecasted to climb from $14 billion in 2024 to $14.91 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.5%. The spike in growth during the historic period can be credited to an upswing in surgical procedures, a proliferating incidence of chronic illnesses, the growth of in-home healthcare, rigorous regulations that guarantee product safety, an amplified emphasis on patient hydration, and worldwide initiatives for emergency preparedness.
The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $20.1 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to population growth and aging, increasing surgical interventions, rising incidence of infectious diseases, telemedicine and remote patient monitoring, focus on preventive healthcare, global health security investments, patient-centric care trends. Major trends in the forecast period include increased demand for parenteral nutrition solutions, rise in adoption of pre-mixed iv solutions, expansion of home infusion therapies, introduction of electrolyte-balanced solutions, introduction of novel drug additives and adjuncts, integration of smart iv systems for monitoring.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Intravenous Solutions Market?
The escalating incidence of cancer is anticipated to boost the expansion of the intravenous solutions market in the future. Cancer refers to a myriad of diseases identified by uncontrolled cell proliferation with the capability to infiltrate nearby tissues and metastasize to different body parts. Intravenous solutions play a pivotal role in cancer therapies for delivering chemotherapy drugs and ensuring hydration during treatment. For instance, the World Health Organization, a Switzerland-based intergovernmental organization, forecasted in February 2024 that over 35 million fresh cancer incidences are anticipated by 2050, which is a 77% surge in contrast to the predicted 20 million cases in 2022. Consequently, the escalating incidence of cancer propels the growth of the intravenous solutions market.
Which Primary Segments of the Intravenous Solutions Market Are Driving Growth and Industry Transformations?
The intravenous solutionsmarket covered in this report is segmented –
1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients
3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution
4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings
Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions; Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Intravenous Solutions Market?# Market?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Intravenous Solutions Market?
Companies with a significant presence in the intravenous solutions market are concentrating on the creation of innovative syringes, such as pre-filled and ready-to-use variants, to secure an upper hand in the market. The unique selling point of these syringes is that they come pre-packaged with the medication and are designed for immediate usage without any need for manual filling or configuration. An example to illustrate this trend is the healthcare company based in the US, GENIXUS Corp, who introduced the KinetiXTM Rocuronium Bromide Injection pre-loaded in 5 mL and 10 mL ready-to-administer (RTA) syringes in August 2023. These syringes are constructed from a see-through but robust polymer that negates any risk associated with glass syringes. They are pre-filled and ready to be administered, contributing to saving time and lessening medication errors. Rocuronium bromide injection is intended for intravenous use only. Its notable features include compatibility with KitCheck which is the newest kit and tray management technology, easy-to-understand labeling, and a coloured plunger rod for speedy identification.
View the full report here:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
What Parameters Are Used to Define the Intravenous Solutions Market?
Intravenous solutions are sterile liquids administered directly into a patient’s bloodstream, typically for hydration, medication delivery, or nutrient supplementation. They are used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is impossible.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model